Oncology drug development series - Spotlight on the USA - 28/05/13 Oncology drug development continues to see a high level of activity and funding across the US,
despite an uncertain regulatory environment.
Oncology drug development continues to see a high level of activity and funding across the US,
despite an uncertain regulatory environment that has left many Big Pharma companies carefully considering their R&D investments and strategies.
Turkish football club continues Bitcoin sports trend by signing player to be paid in Bitcoin,
despite uncertain regulatory environment.